IAS 2017

Protocol

Title

Authors

Presentation Type, Time

P1115

Asymptomatic Hematologic Toxicity with Very Early Combination Antiretroviral Therapy (cART) in In Utero HIV-infected Infants

Chadwick EG, Tierney C, Coletti A, Cotton MF, Ruel TD, Reding CA, Zimmer B, Qin M, Jean-Philippe P, Hazra R, Jackson C, Spector S, Capparelli EV, Mirochnick M, Purdue LT, Costello D, Jennings C, Luzuriaga K, Perlowski C, Bwakura-Dangarembizi M, Naidoo KL, Persaud D, Bryson Y for the IMPAACT P1115 Team

Oral presentation

PROMISE

Neurodevelopmental effects of type of antepartum and postpartum PMTCT ARV exposure on Ugandan and Malawian PROMISE HIV-exposed uninfected children at 12, 24, and 48 months of age)

Boivin M, Wambuzi Ogwang, Kawalazira R, Maliwichi-Senganimalunje, Sikorskii A, Familiar-Lopez I, Kuteesa A, Nykato M, Mutebe A, Makitende M, Mallewa M, Aizire J, Taha T, Ruiseñor-Escudero H, Fowler M

Poster

PROMISE

Hepatotoxicity in HIV+ Postpartum Women Initiating Efavirenz-Containing Regimens

Bhattacharya D, Gupta A, Tierney C, Huang S, Peters M, Chipato T, Martinson F, Dula D, George K, Chakhtoura N, Klingman KL, Gnanashanmugam D, Currier J, Fowler MG

Oral presentation

P1060

Long-term metabolic implications of initiating lopinavir/ritonavir-based regimens for infants and children: a follow-up study of IMPAACT P1060

Patel K, Lindsey J, Hernán M, Angelidou K, Aldrovandi G, and Palumbo P, for the IMPAACT P1060 Study Team

Poster

PROMISE 1077BF/1077FF

Hepatotoxicity in HIV+ postpartum women initiating efavirenz-containing regimens

Bhattacharya D, Gupta A, Tierney C, Huang S, Peters M, Chipato T, Martinson F, Dula D, George L, Chakhtoura N, Klingman K, Gnanashanmugam D, Currier J, Fowler MG

Poster

P1026s

Pharmacokinetics of Rifampin and Isoniazid during Pregnancy and Postpartum in South African Women

Van Schalkwyk M, Bekker A, Decloedt E, Theron GB, Cotton MF, Best B, Capparelli E, Stek A, Wang J, Mirochnick M, on behalf of the IMPAACT P1026s Protocol Team

Oral presentation